<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15394-bib-0031">
 <mixed-citation publication-type="journal" id="bjh15394-cit-0031">
  <string-name>
   <surname>Kumar</surname>, 
   <given-names>S.K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bensinger</surname>, 
   <given-names>W.I.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zimmerman</surname>, 
   <given-names>T.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Reeder</surname>, 
   <given-names>C.B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Berenson</surname>, 
   <given-names>J.R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Berg</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hui</surname>, 
   <given-names>A.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gupta</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Di Bacco</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Yu</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Shou</surname>, 
   <given-names>Y.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Niesvizky</surname>, 
   <given-names>R.</given-names>
  </string-name> (
  <year>2014d</year>) 
  <article-title>Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma</article-title>. 
  <source xml:lang="en">Blood</source>, 
  <volume>124</volume>, 
  <fpage>1047</fpage>â€“
  <lpage>1055</lpage>.
  <pub-id pub-id-type="pmid">24904120</pub-id>
 </mixed-citation>
</ref>
